A detailed history of Greenwood Capital Associates LLC transactions in Amgen Inc stock. As of the latest transaction made, Greenwood Capital Associates LLC holds 52,096 shares of AMGN stock, worth $13.8 Million. This represents 2.22% of its overall portfolio holdings.

Number of Shares
52,096
Previous 42,225 23.38%
Holding current value
$13.8 Million
Previous $13.2 Million 27.23%
% of portfolio
2.22%
Previous 1.77%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$309.38 - $337.38 $3.05 Million - $3.33 Million
9,871 Added 23.38%
52,096 $16.8 Million
Q2 2024

Aug 08, 2024

BUY
$262.75 - $319.31 $1.96 Million - $2.39 Million
7,472 Added 21.5%
42,225 $13.2 Million
Q1 2024

May 01, 2024

BUY
$268.87 - $324.56 $3.65 Million - $4.41 Million
13,580 Added 64.14%
34,753 $9.88 Million
Q4 2023

Mar 05, 2024

SELL
$255.7 - $288.46 $11,762 - $13,269
-46 Reduced 0.22%
21,173 $6.1 Million
Q3 2023

Oct 18, 2023

SELL
$218.65 - $271.46 $60,566 - $75,194
-277 Reduced 1.29%
21,219 $5.7 Million
Q2 2023

Aug 07, 2023

BUY
$214.27 - $253.37 $413,755 - $489,257
1,931 Added 9.87%
21,496 $4.77 Million
Q1 2023

May 12, 2023

BUY
$225.79 - $275.2 $4.42 Million - $5.38 Million
19,565 New
19,565 $4.73 Million
Q2 2018

Aug 07, 2018

SELL
$166.05 - $186.51 $2.61 Million - $2.93 Million
-15,696 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $22,025 - $25,740
130 Added 0.84%
15,696 $2.68 Million
Q4 2017

Feb 02, 2018

SELL
$168.79 - $188.59 $169,633 - $189,532
-1,005 Reduced 6.06%
15,566 $2.71 Million
Q3 2017

Nov 03, 2017

BUY
$167.29 - $191.0 $2.77 Million - $3.17 Million
16,571
16,571 $3.09 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Greenwood Capital Associates LLC Portfolio

Follow Greenwood Capital Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.